Clinical Trial Update: HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study [Phase 3]

View source ↗

Summary

Phase 3 trial comparing HAIC with one-day FOLFOX versus two-day FOLFOX for unresectable hepatocellular carcinoma; currently recruiting non-inferiority study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: RECRUITING